| Acute Respiratory Distress Syndrome |
1 |
1 |
| Lung |
0 |
0.76 |
| Mechanical Ventilation |
0 |
0.67 |
| COVID-19 |
0 |
0.62 |
| Lung Fibrosis |
0 |
0.58 |
| Wound Management |
0 |
0.47 |
| Pneumonia |
0 |
0.41 |
| Epithelium |
0 |
0.4 |
| Disaster Medicine |
0 |
0.35 |
| Pulmonary Edema |
0 |
0.28 |
| Noncardiogenic Pulmonary Edema |
0 |
0.26 |
| Stem Cell Research and Therapy |
0 |
0.23 |
| Edema |
0 |
0.22 |
| Heart Failure (HF) |
0 |
0.22 |
| Injury |
0 |
0.22 |
| Ventilator |
0 |
0.18 |
| Sepsis |
0 |
0.16 |
| Blood |
0 |
0.13 |
| Blood Transfusion |
0 |
0.13 |
| Idiopathic Pulmonary Fibrosis |
0 |
0.13 |
| Tissue |
0 |
0.13 |
| Heart |
0 |
0.09 |
| Scar |
0 |
0.09 |
| Abdominal Infection |
0 |
0.08 |
| Cystic Fibrosis |
0 |
0.08 |
| Genomic Medicine |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Pancreatitis |
0 |
0.08 |